N-(3,4-Dichlorophenyl)-N'-(2-chlorophenyl)urea
|
- $29.8 - $501.53
- Product name: N-(3,4-Dichlorophenyl)-N'-(2-chlorophenyl)urea
- CAS: 13208-22-5
- MF: C13H9Cl3N2O
- MW: 315.58
- EINECS:
- MDL Number:MFCD00018182
- Synonyms:2,3',4'-Trichlorocarbanilide;N-(3,4-Dichlorophenyl)-N'-(2-chlorophenyl)urea;1-(2-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA;Urea, N-(2-chlorophenyl)-N'-(3,4-dichlorophenyl)-
3 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 250MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0109438
- Product description1-(2-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA 95.00%
- Packaging5MG
- Price$501.53
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS590495
- Product description2,3,4''-TRICHLOROCARBANILIDE AldrichCPR
- Packaging250MG
- Price$29.8
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product numberS644455
- Product description1-(2-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA Aldrich
- Packaging250mg
- Price$110
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0109438 | 1-(2-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA 95.00% | 5MG | $501.53 | 2021-12-16 | Buy |
| Sigma-Aldrich | S590495 | 2,3,4''-TRICHLOROCARBANILIDE AldrichCPR | 250MG | $29.8 | 2024-03-01 | Buy |
| Sigma-Aldrich | S644455 | 1-(2-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA Aldrich | 250mg | $110 | 2024-03-01 | Buy |
Properties
Melting point :220.0-220.6 °C
Boiling point :340.5±42.0 °C(Predicted)
Density :1.534±0.06 g/cm3(Predicted)
pka :12.65±0.70(Predicted)
Boiling point :340.5±42.0 °C(Predicted)
Density :1.534±0.06 g/cm3(Predicted)
pka :12.65±0.70(Predicted)
Safety Information
| Symbol(GHS): |
 
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||
| Precautionary statements: |
|